Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 1:13 PM
Ignite Modification Date: 2025-12-24 @ 1:13 PM
NCT ID: NCT01759095
Eligibility Criteria: Inclusion Criteria: * Age over 18 years * Prescription of 4 or more different oral solid drugs * Capable to understand german (verbally and written) * Capable to give informed consent * Insured by a Swiss health insurance * Manages his/her pharmacotherapy without external support * Obtains his/her medication from a community pharmacy * Accepts to use an electronic multidrug blister pack * Place of domicile in Basel-Stadt or Basel-Land Exclusion Criteria: * Pregnancy * \> 2 drugs that cannot be packed into a multidrug blister pack (e.g. fluids) * Dementia, or evaluated as cognitively impaired by the responsible nurse * Transplanted patient * Anticoagulation with oral vitamin K antagonists * Has already used a multidrug blister pack of Pharmis or a MedifilmĀ® single dose system * is visually impaired (blind) * cannot push drugs through a blister * refuses to allow contact to his/her regular pharmacy and GP * is referred to a nursing home or to rehabilitation or another hospital at discharge * is included in other clinical trial
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT01759095
Study Brief:
Protocol Section: NCT01759095